Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adverse Outcome Pathways--Organizing Toxicological Information to Improve Decision Making
Stephen W. Edwards, Yu‐Mei Tan, Daniel L. Villeneuve, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 356, Iss. 1, pp. 170-181
Open Access | Times Cited: 184

Showing 1-25 of 184 citing articles:

Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009
Niklas Andersson, Maria Arena, Domenica Auteri, et al.
EFSA Journal (2018) Vol. 16, Iss. 6
Open Access | Times Cited: 442
Glyphosate toxicity and carcinogenicity: a review of the scientific basis of the European Union assessment and its differences with IARC
José Tarazona, Daniele Court-Marques, Manuela Tiramani, et al.
Archives of Toxicology (2017) Vol. 91, Iss. 8, pp. 2723-2743
Open Access | Times Cited: 347
Adverse outcome pathways: opportunities, limitations and open questions
Marcel Leist, Ahmed Ghallab, Rabea Graepel, et al.
Archives of Toxicology (2017) Vol. 91, Iss. 11, pp. 3477-3505
Open Access | Times Cited: 326
Green Chemistry in the Synthesis of Pharmaceuticals
Supratik Kar, Hans Sanderson, Kunal Roy, et al.
Chemical Reviews (2021) Vol. 122, Iss. 3, pp. 3637-3710
Closed Access | Times Cited: 305
Integrating tools for non-targeted analysis research and chemical safety evaluations at the US EPA
Jon R. Sobus, John F. Wambaugh, Kristin Isaacs, et al.
Journal of Exposure Science & Environmental Epidemiology (2017) Vol. 28, Iss. 5, pp. 411-426
Open Access | Times Cited: 193
From the exposome to mechanistic understanding of chemical-induced adverse effects
Beate I. Escher, Jörg Hackermüller, Tobias Polte, et al.
Environment International (2016) Vol. 99, pp. 97-106
Open Access | Times Cited: 186
One planet: one health. A call to support the initiative on a global science–policy body on chemicals and waste
Werner Brack, Damià Barceló i Cullerés, Alistair B.A. Boxall, et al.
Environmental Sciences Europe (2022) Vol. 34, Iss. 1
Open Access | Times Cited: 75
CTD tetramers: a new online tool that computationally links curated chemicals, genes, phenotypes, and diseases to inform molecular mechanisms for environmental health
Allan Peter Davis, Thomas C. Wiegers, Jolene Wiegers, et al.
Toxicological Sciences (2023) Vol. 195, Iss. 2, pp. 155-168
Open Access | Times Cited: 53
Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use
Michael Aschner
ALTEX (2016)
Open Access | Times Cited: 141
Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment
Edward J. Perkins, Roman Ashauer, Lyle D. Burgoon, et al.
Environmental Toxicology and Chemistry (2019) Vol. 38, Iss. 9, pp. 1850-1865
Open Access | Times Cited: 135
Adverse outcome pathways: a concise introduction for toxicologists
Mathieu Vinken, Dries Knapen, Lucia Vergauwen, et al.
Archives of Toxicology (2017) Vol. 91, Iss. 11, pp. 3697-3707
Open Access | Times Cited: 134
Cumulative effects of antiandrogenic chemical mixtures and their relevance to human health risk assessment
Kembra L. Howdeshell, Andrew K. Hotchkiss, L. Earl Gray
International Journal of Hygiene and Environmental Health (2016) Vol. 220, Iss. 2, pp. 179-188
Open Access | Times Cited: 118
Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity
Anna Bal‐Price, M.E. Meek
Pharmacology & Therapeutics (2017) Vol. 179, pp. 84-95
Open Access | Times Cited: 105
A history of the roles of cytochrome P450 enzymes in the toxicity of drugs
F. Peter Guengerich
Toxicological Research (2020) Vol. 37, Iss. 1, pp. 1-23
Open Access | Times Cited: 105
The Adverse Outcome Pathway approach in nanotoxicology
Kirsten Gerloff, Brigitte Landesmann, Andrew Worth, et al.
Computational Toxicology (2016) Vol. 1, pp. 3-11
Open Access | Times Cited: 96
Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies
Francesca Pistollato, Federica Madia, Raffaella Corvi, et al.
Archives of Toxicology (2021) Vol. 95, Iss. 6, pp. 1867-1897
Open Access | Times Cited: 96
The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation
Antone L. Brooks, David G. Hoel, R. Julian Preston
International Journal of Radiation Biology (2016) Vol. 92, Iss. 8, pp. 405-426
Open Access | Times Cited: 93
Development and analysis of an adverse outcome pathway network for human neurotoxicity
Nicoleta Spînu, Anna Bal‐Price, Mark T.D. Cronin, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 10, pp. 2759-2772
Open Access | Times Cited: 77
PFAS use in electronic products and exposure risks during handling and processing of e-waste: A review
Berrin Tansel
Journal of Environmental Management (2022) Vol. 316, pp. 115291-115291
Closed Access | Times Cited: 61
An integrative data-centric approach to derivation and characterization of an adverse outcome pathway network for cadmium-induced toxicity
Ajaya Kumar Sahoo, Nikhil Chivukula, K.H. Ramesh, et al.
The Science of The Total Environment (2024) Vol. 920, pp. 170968-170968
Open Access | Times Cited: 11
Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity
Anna Bal‐Price, Pamela J. Lein, Kimberly P. Keil, et al.
NeuroToxicology (2016) Vol. 59, pp. 240-255
Open Access | Times Cited: 86
Review: <i>Pharmaceutical and personal care products (PPCPs) as endocrine disrupting contaminants (EDCs) in South African surface waters</i>
Edward Archer, Gideon Wolfaardt, J.H. van Wyk
Water SA (2017) Vol. 43, Iss. 4, pp. 684-684
Open Access | Times Cited: 80
Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement
Molly Morgan, Brian P. Johnson, Megan K. Livingston, et al.
Pharmacology & Therapeutics (2016) Vol. 165, pp. 79-92
Open Access | Times Cited: 73
Evolution of chemical-specific adjustment factors (CSAF) based on recent international experience; increasing utility and facilitating regulatory acceptance
Virunya S. Bhat, M.E. Meek, Mathieu Valcke, et al.
Critical Reviews in Toxicology (2017) Vol. 47, Iss. 9, pp. 733-753
Open Access | Times Cited: 73
Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole
Claudia Luckert, Albert Braeuning, Georges de Sousa, et al.
Chemical Research in Toxicology (2018) Vol. 31, Iss. 8, pp. 784-798
Open Access | Times Cited: 71
Page 1 - Next Page

Scroll to top